VANCOUVER, British Columbia — Zymo Research Corporation will launch its Quick-cfRNA™ Serum & Plasma Kit, which is currently in beta test, at ASHG 2016, Booth #112. Genetic researchers who need a reliable and robust method to purify cell-free RNA (cfRNA) from up to 1 ml of plasma, serum, or other biological fluids can use the Quick-cfRNA™ Serum & Plasma Kit. Isolated RNA is immediately ready for sensitive downstream applications including RT-qPCR and Next Generation Sequencing. The kit enables simple, reliable, and efficient preparation of high-quality circulating cell-free RNA (including protein-bound, exosomal, miRNA and other small RNAs) from serum, plasma, amniotic fluid, cerebrospinal fluid, saliva, and other biological fluids. Cell-free RNA naturally occurs in blood and has clinical significance. It is becoming a promising tool for non-invasive and cost effective detection of cancer and other diseases.

In addition to the new Quick-cfRNA Serum & Plasma Kit, Zymo Research will also be sh